Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Enterprise Value (2016 - 2025)

Bio-Techne has reported Enterprise Value over the past 17 years, most recently at -$172.9 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$172.9 million for Q4 2025, up 4.37% from a year ago — trailing twelve months through Dec 2025 was -$172.9 million (up 4.37% YoY), and the annual figure for FY2025 was -$165.0 million, down 7.96%.
  • Enterprise Value for Q4 2025 was -$172.9 million at Bio-Techne, down from -$145.0 million in the prior quarter.
  • Over the last five years, Enterprise Value for TECH hit a ceiling of -$135.7 million in Q4 2023 and a floor of -$279.4 million in Q4 2021.
  • Median Enterprise Value over the past 5 years was -$182.6 million (2022), compared with a mean of -$188.7 million.
  • Biggest five-year swings in Enterprise Value: surged 32.31% in 2023 and later crashed 33.26% in 2024.
  • Bio-Techne's Enterprise Value stood at -$279.4 million in 2021, then rose by 29.59% to -$196.8 million in 2022, then skyrocketed by 31.06% to -$135.7 million in 2023, then crashed by 33.26% to -$180.8 million in 2024, then grew by 4.37% to -$172.9 million in 2025.
  • The last three reported values for Enterprise Value were -$172.9 million (Q4 2025), -$145.0 million (Q3 2025), and -$165.0 million (Q2 2025) per Business Quant data.